Reducing and managing systemic reactions to immunotherapy

Anupama Ravi, Matthew A. Rank

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Purpose of review To identify and discuss recent articles pertaining to the reduction and management of systemic reactions to allergen immunotherapy (AIT). Recent findings Fatal reactions to AIT may be declining. Screening asthma patients before AIT and dose adjustment during pollen season may contribute to lower systemic reaction rates. Cluster build-up protocols with multiallergen subcutaneous immunotherapy (SCIT) may lead to an increased risk of systemic reactions compared with cluster build-up protocols with single-allergen SCIT. Sublingual immunotherapy (SLIT) studies confirm the low rates of systemic reactions using this method, including for rapid build-up schedules. Studies of newer forms of AIT (intralymphatic, epicutaneous, recombinant allergens) have too few patients to form confident systemic reaction risk estimates. High-grade delayed systemic reactions to AIT may be less frequent than previously reported. Summary Recent studies increase confidence in risk estimates for systemic reactions to AIT, suggest useful strategies to predict systemic reactions to AIT, and offer strategies to prevent systemic reactions.

Original languageEnglish (US)
Pages (from-to)651-655
Number of pages5
JournalCurrent Opinion in Allergy and Clinical Immunology
Issue number6
StatePublished - Dec 2013


  • Desensitization
  • Hypersensitivity
  • Immunologic
  • Immunotherapy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Reducing and managing systemic reactions to immunotherapy'. Together they form a unique fingerprint.

Cite this